Business

Cannabis ETFs get high on DEA reclassification news

The Biden admin is moving to weaken restrictions on cannabis, according to a report by the Associated Press.

Marijuana has been classified as a Schedule I drug (on par with heroin) since the Controlled Substances Act was first signed in 1970.

This change would make cannabis, which is recreationally legal in 24 states, a Schedule III drug (on par with anabolic steroids). The shift, which isn't finalized, would likely give a significant boost to the $35B legal cannabis industry through changes to its tax status.

Cannabis stocks and ETFs soared on the news.

More Business

See all Business

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.